IRD vs KEYS · rev $11.0M vs P/E 57, rev $4.98B
Opus Genetics, Inc. (IRD) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
IRD currently screens at market cap $35.7M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the IRD and KEYS stock pages for the full models.
Not investment advice.